Clobazam Patent Expiration
Clobazam is Used for managing seizure disorders. It was first introduced by Lundbeck Pharmaceuticals Llc
Clobazam Patents
Given below is the list of patents protecting Clobazam, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Sympazan | US11541002 | Oral film compositions and dosage forms having precise active dissolution profiles | Jan 31, 2040 | Otter Pharms |
Sympazan | US8603514 | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
Apr 03, 2024
(Expired) | Otter Pharms |
Sympazan | US8765167 | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
Feb 20, 2024
(Expired) | Otter Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Clobazam's patents.
Latest Legal Activities on Clobazam's Patents
Given below is the list recent legal activities going on the following patents of Clobazam.
Event | Date | Patent/Publication |
---|---|---|
![]() | ||
Patent Issue Date Used in PTA Calculation | 03 Jan, 2023 | US11541002 |
Recordation of Patent Grant Mailed | 03 Jan, 2023 | US11541002 |
Issue Notification Mailed | 14 Dec, 2022 | US11541002 |
Application Is Considered Ready for Issue | 29 Nov, 2022 | US11541002 |
Dispatch to FDC | 29 Nov, 2022 | US11541002 |
Workflow - Drawings Finished | 28 Nov, 2022 | US11541002 |
PUB Other miscellaneous communication to applicant | 03 Nov, 2022 | US11541002 |
Mail PUB other miscellaneous communication to applicant | 03 Nov, 2022 | US11541002 |
Issue Fee Payment Received | 27 Oct, 2022 | US11541002 |
Issue Fee Payment Verified | 27 Oct, 2022 | US11541002 |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳
Clobazam Generics
Several generic applications have been filed for Clobazam. The first generic version for Clobazam was by Bionpharma Inc and was approved on Oct 22, 2018. And the latest generic version is by Accord Healthcare Inc and was approved on Sep 6, 2022.
Given below is the list of companies who have filed for Clobazam generic.
1. TARO
Taro Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Taro.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Discontinued | ORAL | N/A | Oct 22, 2018 |
20MG | tablet | Discontinued | ORAL | N/A | Oct 22, 2018 |
2.5MG/ML | suspension | Prescription | ORAL | AB | Apr 15, 2019 |
2. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Clobazam. Given below are the details of the strengths of this generic introduced by Amneal.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG/ML | suspension | Prescription | ORAL | AB | Oct 22, 2018 |
3. MICRO LABS
Micro Labs Ltd has filed for 2 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Micro Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Prescription | ORAL | AB | Jan 30, 2019 |
20MG | tablet | Prescription | ORAL | AB | Jan 30, 2019 |
4. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 3 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
20MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
10MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
2.5MG/ML | suspension | Prescription | ORAL | AB | Feb 24, 2020 |
5. MSN
Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Msn.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Prescription | ORAL | AB | May 11, 2021 |
20MG | tablet | Prescription | ORAL | AB | May 11, 2021 |
6. VISTAPHARM
Vistapharm Inc has filed for 1 generic for Clobazam. Given below are the details of the strengths of this generic introduced by Vistapharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG/ML | suspension | Discontinued | ORAL | N/A | Jul 10, 2019 |
7. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2020 |
20MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2020 |
8. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Clobazam. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG/ML | suspension | Discontinued | ORAL | N/A | Jan 31, 2020 |
9. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG/ML | suspension | Discontinued | ORAL | N/A | Oct 22, 2018 |
10MG | tablet | Discontinued | ORAL | N/A | Oct 22, 2018 |
20MG | tablet | Discontinued | ORAL | N/A | Oct 22, 2018 |
10. LUPIN LTD
Lupin Ltd has filed for 3 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Prescription | ORAL | AB | Dec 14, 2018 |
20MG | tablet | Prescription | ORAL | AB | Dec 14, 2018 |
2.5MG/ML | suspension | Prescription | ORAL | AB | Dec 28, 2018 |
11. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
20MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
10MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
12. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 2 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
20MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
13. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Discontinued | ORAL | N/A | May 23, 2019 |
20MG | tablet | Discontinued | ORAL | N/A | May 23, 2019 |
2.5MG/ML | suspension | Discontinued | ORAL | N/A | Sep 6, 2022 |
14. BIONPHARMA
Bionpharma Inc has filed for 3 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Bionpharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
20MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
2.5MG/ML | suspension | Prescription | ORAL | AB | Oct 22, 2018 |
15. CELLTRION
Celltrion Inc has filed for 2 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Celltrion.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
20MG | tablet | Discontinued | ORAL | N/A | Dec 9, 2020 |
10MG | tablet | Discontinued | ORAL | N/A | Dec 9, 2020 |
16. MYLAN
Mylan Pharmaceuticals Inc has filed for 1 generic for Clobazam. Given below are the details of the strengths of this generic introduced by Mylan.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG/ML | suspension | Discontinued | ORAL | N/A | Oct 22, 2018 |
17. UPSHER SMITH LABS
Upsher Smith Laboratories Llc has filed for 3 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
20MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
2.5MG/ML | suspension | Discontinued | ORAL | N/A | Oct 22, 2018 |
18. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 3 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Discontinued | ORAL | N/A | Oct 30, 2019 |
20MG | tablet | Discontinued | ORAL | N/A | Oct 30, 2019 |
2.5MG/ML | suspension | Prescription | ORAL | AB | Apr 24, 2020 |
19. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Clobazam. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
2.5MG/ML | suspension | Prescription | ORAL | AB | Mar 24, 2022 |
20. PIRAMAL HLTHCARE UK
Piramal Healthcare Uk Ltd has filed for 2 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Piramal Hlthcare Uk.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
20MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
21. BRECKENRIDGE
Breckenridge Pharmaceutical Inc has filed for 3 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Breckenridge.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Prescription | ORAL | AB | Oct 22, 2018 |
20MG | tablet | Discontinued | ORAL | N/A | Oct 22, 2018 |
5MG | tablet | Discontinued | ORAL | N/A | Oct 19, 2021 |
22. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Clobazam. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
10MG | tablet | Prescription | ORAL | AB | Sep 6, 2019 |
20MG | tablet | Prescription | ORAL | AB | Sep 6, 2019 |
5MG | tablet | Prescription | ORAL | N/A | Dec 21, 2020 |
2.5MG/ML | suspension | Prescription | ORAL | AB | May 6, 2021 |